UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda

PloS one, 2023-07, Vol.18 (7), p.e0288604-e0288604

2023

Volltextzugriff (PDF)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa

AIDS (London), 2013-11, Vol.27 (17), p.2775-2786

2013

Volltextzugriff (PDF)

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial

Annals of internal medicine, 2020-03, Vol.172 (5), p.306

2020

Volltextzugriff (PDF)

Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3232-3238

2012

Volltextzugriff (PDF)

Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis

American journal of hematology, 2023-04, Vol.98 (4), p.588-597

2023

Volltextzugriff (PDF)

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease

Frontiers in immunology, 2023-09, Vol.14, p.1216225-1216225

2023

Volltextzugriff (PDF)

Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection

The Journal of infectious diseases, 2019-07, Vol.220 (3), p.432-441

2019

Volltextzugriff (PDF)

Cluster randomized trial of comprehensive gender-based violence programming delivered through the HIV/AIDS program platform in Mbeya Region, Tanzania: Tathmini GBV study

PloS one, 2018-12, Vol.13 (12), p.e0206074-e0206074

2018

Volltextzugriff (PDF)

WHO's new guidelines for antiretroviral treatment

The Lancet (British edition), 2013-11, Vol.382 (9907), p.1778-1779

2013

Volltextzugriff (PDF)

Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial

PloS one, 2016-06, Vol.11 (6), p.e0157434

2016

Volltextzugriff (PDF)

Modeling the Population Level Effects of an HIV-1 Vaccine in an Era of Highly Active Antiretroviral Therapy

Bulletin of mathematical biology, 2009-04, Vol.71 (3), p.648-680, Article 648

2009

Volltextzugriff (PDF)

T-cell activation is an immune correlate of risk in BCG vaccinated infants

Nature communications, 2016-04, Vol.7 (1), p.11290-11290, Article 11290

2016

Volltextzugriff (PDF)

Hematopoietic stem cell donor vaccination with CMV Triplex augments frequencies of functional and durable CMV-specific T cells in the recipient: a novel strategy to limit antiviral prophylaxis

American journal of hematology, 2023-01, Vol.98 (4), p.588-597

2023

Volltextzugriff (PDF)

Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery

International journal of epidemiology, 2021-03, Vol.50 (1), p.29-30

2021

Volltextzugriff (PDF)

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth

Journal of acquired immune deficiency syndromes (1999), 2012-02, Vol.59 (2), p.185-193

2012

Volltextzugriff (PDF)

Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries

Epidemiology (Cambridge, Mass.), 2017-03, Vol.28 (2), p.224-232

2017

Volltextzugriff (PDF)

Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy

Vaccines (Basel), 2023-09, Vol.11 (9), p.1492

2023

Volltextzugriff (PDF)

AIDS vaccines and preexposure prophylaxis: is synergy possible?

AIDS research and human retroviruses, 2011-06, Vol.27 (6), p.669-680

2011

Volltextzugriff (PDF)

Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates

American journal of epidemiology, 2014-09, Vol.180 (6), p.599-607

2014

Volltextzugriff (PDF)

A strategy for accelerating the development of preventive AIDS vaccines

AIDS (London), 2007-11, Vol.21 (17), p.2259-2263

2007

Volltextzugriff (PDF)

HIV vaccine trials : some design issues including sample size calculation

Journal of acquired immune deficiency syndromes (1988), 1993-05, Vol.6 (5), p.485-496

1993

Volltextzugriff (PDF)

Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA

AIDS (London), 2007-02, Vol.21 (4), p.539-546

Osmanov, S

2007

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)
Dissertationen
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Humans
(28)
Life Sciences & Biomedicine
(27)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Aids/hiv
(12)
Female
(12)
Hiv Infections - Prevention & Control
(12)
Human Immunodeficiency Virus
(12)
Infectious Diseases
(12)
Adult
(11)
Hiv
(10)
Immunology
(10)
Male
(10)
Vaccines
(10)
Aids Vaccines
(9)
Hiv Infections - Epidemiology
(9)
Clinical Trials
(8)
Middle Aged
(8)
Viral Diseases
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines

Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease

Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection

Cluster randomized trial of comprehensive gender-based violence programming delivered through the HIV/AIDS program platform in Mbeya Region, Tanzania: Tathmini GBV study

WHO's new guidelines for antiretroviral treatment

Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial

Modeling the Population Level Effects of an HIV-1 Vaccine in an Era of Highly Active Antiretroviral Therapy

Correction: Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants

T-cell activation is an immune correlate of risk in BCG vaccinated infants

Hematopoietic stem cell donor vaccination with CMV Triplex augments frequencies of functional and durable CMV-specific T cells in the recipient: a novel strategy to limit antiviral prophylaxis

Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth

Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries

Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy

AIDS vaccines and preexposure prophylaxis: is synergy possible?

Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates

A strategy for accelerating the development of preventive AIDS vaccines

HIV vaccine trials : some design issues including sample size calculation

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants

Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA

Suchergebnisse filtern